Empowering Health: Advocating OTC Ivermectin in PA

As a Pennsylvania resident, I strongly urge your support for legislation to permit over-the-counter (OTC) access to ivermectin, emulating recent laws in Arkansas (SB 189, 2025) and Tennessee (SB 2188, 2022). Ivermectin’s proven safety, efficacy, and affordability—demonstrated by decades of global use and a 2015 Nobel Prize—make it a vital tool for health autonomy. This measure would reduce healthcare costs and improve access. By ensuring pharmacist consultation, OTC access would provide safe, regulated use, empowering residents to manage their health responsibly while minimizing reliance on overburdened systems.

COVID-19 Death Statistics: Misinterpretations and Trends

The research analyzed U.S. death statistics from 2000 to 2023, emphasizing that COVID-19 mortality figures may be overstated. Historical data showed a consistent average of around 2.4 million deaths annually until a significant rise began in 2015, culminating in over 3 million deaths by 2023. The author noted personal anecdotes disputing COVID-19 as a direct cause of death in some reported cases. Despite the rollout of vaccines, the death rate continued to exceed pre-pandemic averages, raising questions about vaccine effectiveness and the accuracy of pandemic-related death reporting. The study calls for critical scrutiny of these health crisis narratives.

Health Risks Linked to mRNA Vaccination: What You Need to Know

The post criticizes government officials for spreading misinformation and notes that mRNA vaccines do not prevent infection or transmission and may be harmful. Research from Yale University indicates that vaccinated individuals without prior COVID-19 infection could have spike protein in their bloodstream for over 700 days, alongside a decline in crucial CD4 T cells, which may suggest long-term immune suppression and the need for booster shots. There are also concerns about the integration of vaccine genetic material into human DNA and a notable association between mRNA vaccines and heart issues, especially myocarditis, in young males, particularly after the second dose.